Security key
28036F105
Edgewise Therapeutics, Inc. - Common Stock (EWTX)
CUSIP: 28036F105
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 66,466,915
- Total 13F value
- $594,208,237
- Share change
- +2,075,698
- Put/Call ratio
- 200%
- SEC-reported price per share
- $8.94
- Number of holders
- 90
- Value change
- +$17,736,112
- Number of buys
- 53
- Number of sells
- 29
- Shares outstanding
- 107,555,564
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
90
Top holders
10
EWTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Edgewise Therapeutics, Inc. SEC filings
Edgewise Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 28036F105
Recent filing periods:
Ownership snapshot
Top reported holders of EWTX - Edgewise Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F
3/4/5
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
14%
FMR LLC
7.4%
Novo Holdings A/S
5.6%
VIKING GLOBAL INVESTORS LP
4.1%
DEERFIELD MANAGEMENT COMPANY, L.P.
3.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
14%
|
$143,341,000
14,567,176 shares
|
— | 30 Sep 2022 |
| FMR LLC |
13F
Company
|
7.4%
|
$78,492,000
7,976,813 shares
|
— | 30 Sep 2022 |
| Novo Holdings A/S |
3/4/5
13F
10%+ Owner · Company
|
5.6%
from 13F
|
$95,781,722
6,071,703 shares
|
— | 14 Sep 2022 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
4.1%
|
$43,386,000
4,409,146 shares
|
— | 30 Sep 2022 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
3.7%
|
$38,702,000
3,933,137 shares
|
— | 30 Sep 2022 |
| EcoR1 Capital, LLC |
13F
Company
|
3.2%
|
$34,373,000
3,493,194 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
90
Shares
66,466,915
Rows available
90
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
92
Q4 2022 holders
90
Holder diff
-2
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend